This is an old revision of the document!
Philip Krause
Dr. Philip Krause is an American biotechnology consultant based in Bethesda, Maryland. He is the former Deputy Director of the Office of Vaccines Research & Review at the Food and Drug Administration (FDA).
History
COVID-19
Krause participated in a February 11-12, 2020 event titled “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap” co-hosted by the World Health Organization R&D Blueprint and Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R). He and Anuradha Poonepalli presented on the topic of “Candidate vaccines R&D”.1)
In August 2021, Krause and his superior, Marion Gruber, announced they would be departing their leadership roles at the Food and Drug Administration's Office of Vaccines Research & Review as a result of pressure from the Joe Biden White House to push ahead with COVID-19 vaccine booster doses.2)
He joined Adjuvance Technologies as a consultant in January 2022,3) and Mesoblast in March 2022.4)
External links
1)
2019 novel Coronavirus Global research and innovation forum: towards a research roadmap AGENDA. (2020). GLOPID-R. https://web.archive.org/web/20230208185417/https://www.glopid-r.org/wp-content/uploads/2020/02/covid-19-global-research-and-innovation-forum-2020-program.pdf
2)
Weiland, N., & LaFraniere, S. (2021, August 31). Two Top F.D.A. Vaccine Regulators Are Set to Depart During a Crucial Period. The New York Times. https://archive.ph/gSrJj
3)
Matzner, H., & Martin, T. (2022, January 25). Dr. Philip Krause to Provide Strategic Advice to Adjuvance. Business Wire. https://web.archive.org/web/20230312030822/https://www.businesswire.com/news/home/20220125005493/en/Dr.-Philip-Krause-to-Provide-Strategic-Advice-to-Adjuvance
4)
LaHucik, K. (2022, March 24). Former FDA vaccines deputy Krause heads down under as Mesoblast tries again on nearly entire pipeline. Endpoints News. https://archive.ph/HZdmJ